Ngā hua rapu - Norbert Klause

  • E whakaatu ana i te 1 - 2 hua o te 2
Whakamahine hua
  1. 1
    Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor

    Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor mā Dagmar Kubitza, Michael Becka, Wolfgang Mueck, Atef Halabi, Haidar Maatouk, Norbert Klause, Volkmar Lufft, Dominic D. Wand, Thomas Philipp, Heike Bruck

    I whakaputaina 2010
    Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:
  2. 2
    Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the German STEC-HUS registry

    Best supportive care and therapeutic plasma exchange with or without eculizumab in Shiga-toxin-producing E. coli O104:H4 induced haemolytic–uraemic syndrome: an analysis of the Ger... mā Jan T. Kielstein, Gernot Beutel, Susanne Fleig, Jürgen Steinhoff, Tobias Meyer, Carsten Hafer, Uwe Kuhlmann, Jörn Bramstedt, Ulf Panzer, Martin Vischedyk, Veit Busch, W Ries, Steffen Mitzner, Stefan Mees, Sylvia Stracke, Jens Nürnberger, Peter Gerke, Monika Wiesner, B Sucké, Miriam Abu-Tair, Andreas Kribben, Norbert Klause, Ralf Schindler, Frank Merkel, Sabine Schnatter, Eiske M. Dorresteijn, Ola Samuelsson, R. Brunkhorst

    I whakaputaina 2012
    Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
    Artigo
    Tiaki ki tētahi rārangi
    I tiakina i:

Ngā utauta rapu: